Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...

A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...

Researchers have bioprinted human islets designed to mimic the body’s own tissue structure, allowing them to integrate ...

MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Q: I have Type 1 diabetes. I try to stay healthy and keep my blood sugar under control, but it feels like a fight every day.